Long Non-Coding RNAs: Tools for Understanding and Targeting Cancer Pathways

15Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

The regulatory nature of long non-coding RNAs (lncRNAs) has been well established in various processes of cellular growth, development, and differentiation. Therefore, it is vital to examine their contribution to cancer development. There are ample examples of lncRNAs whose cellular levels are significantly associated with clinical outcomes. However, whether these non-coding molecules can work as either key drivers or barriers to cancer development remains unknown. The current review aims to discuss some well-characterised lncRNAs in the process of oncogenesis and extrapolate the extent of their decisive contribution to tumour development. We ask if these lncRNAs can independently initiate neoplastic lesions or they always need the modulation of well characterized oncogenes or tumour suppressors to exert their functional properties. Finally, we discuss the emerging genetic approaches and appropriate animal and humanised models that can significantly contribute to the functional dissection of lncRNAs in cancer development and progression.

Cite

CITATION STYLE

APA

Pandey, G. K., & Kanduri, C. (2022, October 1). Long Non-Coding RNAs: Tools for Understanding and Targeting Cancer Pathways. Cancers. MDPI. https://doi.org/10.3390/cancers14194760

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free